Latest SONN reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q3 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Sonnet BioTherapeutics Holdings
  4. Financial Ratios
Sonnet BioTherapeutics Holdings logo
Sonnet BioTherapeutics Holdings SONN
$ 1.81 2.86%
mail-toReport an Error

Sonnet BioTherapeutics Holdings Financial Ratios 2011-2024 | SONN

Annual Financial Ratios Sonnet BioTherapeutics Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.1 -0.0 - -1.0 -0.8 -1.0 -1.4 -1.1 -0.8 -462.8 -872.9 -630.7 -

P/S

 11.2 0.5 - - - 0.2 0.2 0.2 0.3 99.3 551.9 226673.6 -

EPS

 -18.1 -150.5 -14.2 -7.0 -2.6 -2.0 -2.7 -4.2 -0.9 -0.9 -1.2 -1.2 -1.0

EV (Enterprise Value)

 5.02 M 5.51 M -20.9 M 22.8 M 6.29 M 28.6 M 29 M 29.8 M 29.3 M 2.98 B 4.56 B 734 M 4.16 M

EBITDA per Share

 -18.1 -150 -14.3 -2.57 -22.9 -26.2 -31.4 -3.33 -67.5 -0.389 -0.783 -0.71 -

EV/EBITDA

 0.8 -0.7 -0.8 -3.7 -4.4 -48.5 -2.6 -1204.2 -1332.0 -870.4 -1.2

PEG

 -0.0 -0.0 - -0.01 -0.02 -0.04 -0.04 -0.02 0.0 -30.17 40.17 6.83 -

P/B

 -7.4 -0.1 - 8.3 -1.4 0.9 0.9 0.7 0.5 197.9 405.0 132.6 -

P/CF

 -0.1 -0.0 - 139.9 -1.8 -2.4 -4.2 -5.6 -1.4 -988.9 -715.4 -532.7 -

ROE %

 8333.79 1170.74 -112.24 -803.50 171.19 -92.25 -63.46 -70.29 -56.80 -42.77 -46.39 -21.03 -208.24

ROA %

 -346.86 -509.81 -86.17 -303.53 -12253.39 -23.01 -22.51 -27.11 -28.76 -17.89 -25.96 -15.21 -21.08

ROCE %

 8316.05 1168.67 -112.70 -741.23 165.47 -32.02 -34.89 -12.26 -20.73 -22.74 -31.65 -16.27 -93.82

Current Ratio

 1.0 0.7 4.3 1.6 0.0 0.1 0.1 0.1 0.2 0.1 0.3 1.1 0.2

DSO

 - - - - - 3.9 4.2 4.6 9.6 3.4 10.1 18173.6 343.7

DIO

 - - - - - 4.4 4.5 5.5 8.4 366.9 - - -

DPO

 - - - - - - - - - 3843.1 - - -

Operating Cycle

 - - - - - 8.2 8.7 10.1 18.0 370.3 - - -

Cash Conversion Cycle

 - - - - - 8.2 8.7 10.1 18.0 -3472.8 - - -

All numbers in USD currency

Quarterly Financial Ratios Sonnet BioTherapeutics Holdings

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 0.08 -0.31 - -0.13 -7.55 -17.62 -0.37 -1.82 -1.91 -1.44 -0.93 -0.27 -0.32 -0.34 -2.23 -1.05 -0.34 -0.44 -0.39 -0.26 -13.28 - -0.34 -0.23 -0.83 - -0.7 -0.81 -0.79 - -0.41 -2.35 -0.07 - -0.31 -0.24 -0.27 - -0.52 -0.07 -0.24 - -0.38 -0.19 -0.2 - -0.2 -0.56 -0.28 - -0.4 -0.18 0.11

EBITDA per Share

 - -0.34 - - - -17.8 -4.02 -1.82 -1.91 -1.44 -0.93 -0.28 -0.32 -0.34 -2.23 -1.04 -0.32 -0.44 -0.37 -0.16 -8.63 - -0.04 0.03 -0.58 - -0.33 -0.2 -0.18 - 0.03 0.03 -0.02 - -0.05 -0.11 -0.23 - -0.01 -0.02 -0.26 - -0.16 -0.12 -0.18 - -0.13 -0.31 -0.17 - -0.22 -0.18 0.11

ROE %

 -264.37 -381.89 -64.33 813.53 -101.76 -92.40 -286.91 -1245.78 -661.87 -864.30 -590.17 -272.87 410.26 945.17 811.78 662.26 402.42 173.99 67.16 -36.27 -22.96 -65.78 -77.83 -77.15 -85.10 -50.29 -57.49 -48.71 -70.74 -58.76 -79.52 -93.08 -69.21 -47.53 -51.21 -34.13 -21.33 -16.85 -32.32 -44.10 -46.84 -28.32 -41.70 -39.62 -48.59 -41.37 -143.43 -232.10 -263.36 -102.11 -102.06 -46.52 46.46

ROA %

 -94.37 -143.13 -194.03 -576.30 -642.14 -654.12 -571.90 -251.82 -231.87 -198.14 -362.03 -373.35 -361.64 -414.33 -228.38 -6365.70 -6295.30 -6222.37 -6215.52 -8.84 -8.28 -16.41 -21.09 -22.61 -26.50 -17.84 -20.54 -17.57 -26.21 -22.05 -32.75 -40.75 -34.09 -24.50 -26.04 -16.88 -10.00 -7.13 -14.22 -19.77 -21.74 -14.28 -23.95 -26.54 -34.06 -29.91 -40.24 -40.90 -34.58 -10.34 -10.33 -4.71 4.70

ROCE %

 -405.44 -384.30 -61.38 816.71 -98.22 -88.92 -285.50 -1245.09 -671.52 -873.83 -600.15 154.63 1083.59 1617.88 1485.01 960.50 464.09 275.31 163.37 5.56 23.25 -46.73 -59.79 -63.82 -68.27 -32.40 -36.52 -27.58 -21.60 -15.45 -20.43 -21.29 -24.46 -21.02 -24.57 -23.14 -19.27 -17.49 -28.09 -35.15 -37.84 -23.62 -37.39 -40.56 -45.89 -34.43 -93.34 -138.48 -174.26 -62.03 -58.91 -47.23 44.12

Current Ratio

 2.1 1.9 1.0 1.5 1.7 0.6 0.7 1.1 2.3 4.8 4.3 1.2 4.3 0.6 1.6 1.6 1.6 0.9 0.0 1.2 1.2 1.4 1.4 1.4 1.4 1.6 1.6 1.6 1.6 1.7 1.7 1.7 1.7 2.1 2.1 2.1 2.1 1.7 1.7 1.7 1.7 2.3 2.3 2.3 2.3 3.6 3.6 3.6 3.6 1.1 1.1 1.1 1.1

DSO

 - - - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

All numbers in USD currency